1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Ireland Pharmaceuticals and Healthcare Report Q3 2016

Ireland Pharmaceuticals and Healthcare Report Q3 2016

  • June 2016
  • -
  • Business Monitor International
  • -
  • 76 pages

Includes 3 FREE quarterly updates

BMI View: The export-oriented Irish pharmaceutical industry will continue to benefit from its R&D andmanufacturing capabilities as well as its competitive business environment. While the new US federal ruleson so-called corporate inversion deals will mitigate purely tax-driven acquisitions of Irish pharmaceuticalequities by US-based companies, the highly developed Irish drug sector and its international role willcontinue to promote its appeal to investors. Meanwhile, we expect the Irish economy to remain anoutperformer among developed countries over the next few years, which will continue to support therecovering domestic pharmaceutical and healthcare markets.

Headline Expenditure Projections

- Pharmaceuticals: EUR2.32bn (USD2.57bn) in 2015 to EUR2.27bn (USD2.43bn) in 2016; -1.9% inlocal currency terms and -5.4% in US dollar terms. Forecast broadly in line with last quarter.

- Healthcare: EUR14.98bn (USD16.61bn) in 2015 to EUR15.28bn (USD16.35bn) in 2016; +2.0% in localcurrency terms and -1.6% in US dollar terms. Forecast revised upwards from last quarter.

Table Of Contents

Ireland Pharmaceuticals and Healthcare Report Q3 2016
BMI Industry View 7
Table: Headline Pharmaceuticals and Healthcare Forecasts (Ireland 2014-2020) 7
SWOT 9
Industry Forecast 11
Pharmaceutical Market Forecast 11
Table: Pharmaceutical Sales, Historical Data And Forecasts (Ireland 2012-2020) 14
Healthcare Market Forecast 15
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Ireland 2012-2020) 18
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Ireland 2012-2020) 18
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Ireland 2012-2020) 18
Prescription Drug Market Forecast 19
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Ireland 2012-2020) 22
OTC Medicine Market Forecast 23
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Ireland 2012-2020) 24
Pharmaceutical Trade Forecast 25
Table: Top 15 Pharmaceuticals and Healthcare Export Companies In 2013 27
Table: Pharmaceutical Trade Data And Forecasts (Ireland 2014-2020) 27
Table: Pharmaceutical Trade Data And Forecasts local currency (Ireland 2014-2020) 28
Industry Risk/Reward Index 29
Western Europe Risk/Reward Index 29
Ireland Risk/Reward Index 34
Rewards 34
Risks 35
Regulatory Review 36
Pricing Regime 41
Reimbursement Regime 44
Market Overview 48
Healthcare Sector 49
Table: Health Status 52
Table: Healthcare Funding 52
Table: Healthcare Resources (Ireland 2010-2015) 53
Table: Healthcare Personnel (Ireland 2010-2015) 53
Table: Healthcare Activity (Ireland 2010-2015) 54
Research and Development 54
Clinical Trials 55
Epidemiology 56
Competitive Landscape 59
Research-Based Industry 59
Table: Multinational Market Activity 61
Table: Pharmaceutical Companies In Ireland 62
Generic Drugmakers 63
Pharmaceutical Distribution 64
Demographic Forecast 65
Table: Population Headline Indicators (Ireland 1990-2025) 66
Table: Key Population Ratios (Ireland 1990-2025) 66
Table: Urban/Rural Population and Life Expectancy (Ireland 1990-2025) 67
Table: Population By Age Group (Ireland 1990-2025) 67
Table: Population By Age Group % (Ireland 1990-2025) 68
Glossary 70
Methodology 72
Pharmaceutical Expenditure Forecast Model 72
Healthcare Expenditure Forecast Model 72
Notes On Methodology 73
Risk/Reward Index Methodology 74
Index Overview 75
Table: Pharmaceutical Risk/Reward Index Indicators 75
Indicator Weightings 76

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

  • $ 10995
  • Industry report
  • September 2016
  • by Global Data

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024 Summary Attention deficit hyperactivity disorder (ADHD) is characterized by excessive levels ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

  • $ 6995
  • Industry report
  • November 2016
  • by GBI Research

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation Summary Asthma is a chronic condition affecting ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.